Delayed Device Embolization After TEER of the Mitral Valve as a Rare But Dangerous Complication
- PMID: 40883090
- PMCID: PMC12402382
- DOI: 10.1016/j.jaccas.2025.104822
Delayed Device Embolization After TEER of the Mitral Valve as a Rare But Dangerous Complication
Abstract
Background: Delayed device embolization is a rare but dangerous complication after transcatheter edge-to-edge repair (TEER).
Case summary: A 79-year-old man with acute decompensated severe structural mitral regurgitation underwent TEER with 2 clips after failed medical attempts at recompensation. Six days later, 1 clip embolized into the abdominal aorta, resulting in recurrent, progressive decompensation and severe mitral regurgitation, requiring urgent mitral valve replacement. Despite initial stabilization, the patient died because of septic complications.
Discussion: Although delayed device embolization is rare, it may be underreported in the current literature and can have serious consequences. This underscores the importance of careful heart team evaluation when choosing between interventional vs surgical strategies.
Take-home message: Device embolization after TEER must be discussed as a rare but serious complication, and particular attention should be given to close post-TEER monitoring, especially in patients with complex anatomy.
Keywords: embolization; mitral valve; mitral valve replacement; transcatheter-edge-to-edge-repair.
Copyright © 2025 The Authors. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Funding Support and Author Disclosures Dr Caldonazo has been funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) Clinician Scientist Program OrganAge (funding number 413668513), Bonn, Germany, the Deutsche Herzstiftung (DHS, German Heart Foundation) (funding number S/03/23), Frankfurt am Main, Germany, and the Interdisciplinary Center of Clinical Research of the Medical Faculty Jena, Germany. The authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Figures
References
-
- Mauri L., Foster E., Glower D.D., et al. 4-Year results of a randomized controlled trial of percutaneous repair versus surgery for mitral regurgitation. J Am Coll Cardiol. 2013;62:317–328. - PubMed
-
- Vahanian A., Beyersdorf F., Praz F., et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2022;43:561. - PubMed
-
- Sorajja P., Vemulapalli S., Feldman T., et al. Outcomes with transcatheter mitral valve repair in the United States: an STS/ACC TVT registry report. J Am Coll Cardiol. 2017;70:2315–2327. - PubMed
-
- von Bardeleben R.S., Mahoney P., Morse M.A., et al. 1-Year outcomes with fourth-generation mitral valve transcatheter edge-to-edge repair from the EXPAND G4 study. JACC Cardiovasc Interv. 2023;16:2600–2610. - PubMed
-
- Nagai M., Kurokawa S., Ozaki M., Nomura M. Attachment of a migrated MitraClip to the left ventricular apex: a novel case report. Echocardiography. 2020;37:139–141. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
